CEFAZOLIN SODIUM

Post-LOE

cefazolin sodium

Teva

ANDAINJECTIONINJECTABLE

Approved

Nov 2006

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

CEFAZOLIN SODIUM (cefazolin sodium) by Teva is [see microbiology () ]. Approved for the following infections, the treatment of the following infections caused by susceptible isolates of the designated microorganisms: respiratory tract infections (). First approved in 2006.

Drug data last refreshed 22h ago

Mechanism of Action

[see Microbiology () ].

Indications (2)

the following infections the treatment of the following infections caused by susceptible isolates of the designated microorganisms: Respiratory tract infections ()

Worked on CEFAZOLIN SODIUM at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.